What if we could reliably predict preeclampsia in pregnant women with an at-home test?

Preeclampsia (PE) complicates 5-7% of pregnancies and is a major cause of maternal and neonatal morbidity and mortality. Accurate diagnosis remains a key challenge. We have some molecular tests for this condition, but they rely on expensive, blood-based platforms – systems that require trained laboratory technologists and hospital-based laboratories. Our goal is to develop and validate a point-of-care test that can be readily used by mothers at home for early detection of PE.

Topic 1: Women's Health at Home